CN Patent

CN104337782A — 一种甲磺酸伊马替尼片剂

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2015-02-11 · 11y expired

What this patent protects

本发明公开了一种甲磺酸伊马替尼片剂，由包含如下重量份的组分混匀后采用粉末直接压片法制备而成：甲磺酸伊马替尼1份、微粉硅胶0.1-1份、填充剂2-8份、崩解剂0.1-1份和润滑剂0.05-1份。本发明涉及的甲磺酸伊马替尼片采用直接压片技术，粉末流动性较好，片重稳定，外观光洁良好，并且药物溶出迅速，生产成本低，适合工业化大生产。

USPTO Abstract

本发明公开了一种甲磺酸伊马替尼片剂，由包含如下重量份的组分混匀后采用粉末直接压片法制备而成：甲磺酸伊马替尼1份、微粉硅胶0.1-1份、填充剂2-8份、崩解剂0.1-1份和润滑剂0.05-1份。本发明涉及的甲磺酸伊马替尼片采用直接压片技术，粉末流动性较好，片重稳定，外观光洁良好，并且药物溶出迅速，生产成本低，适合工业化大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104337782A
Jurisdiction
CN
Classification
—
Expires
2015-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.